These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10102158)

  • 1. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
    Alpay F; Sarici SU; Okutan V; Erdem G; Ozcan O; Gökçay E
    Acta Paediatr; 1999 Feb; 88(2):216-9. PubMed ID: 10102158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility].
    Rübo J; Wahn V
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():104-8; discussion 109. PubMed ID: 8499737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
    Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
    J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
    Alcock GS; Liley H
    Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
    Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M
    J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia caused by non-D minor blood incompatibilities in a newborn.
    Tugcu AU; Ince DA; Turan O; Belen B; Olcay L; Ecevit A
    Pan Afr Med J; 2019; 33():262. PubMed ID: 31692740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
    Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
    Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine administration of intravenous calcium during exchange blood transfusion for treatment of severe neonatal hyperbilirubinaemia: a systematic review of quantitative evidence protocol.
    Orimadegun AE; Akingbola TS
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):134-45. PubMed ID: 26447014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
    Dağoğlu T; Ovali F; Samanci N; Bengisu E
    J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.